An umbrella review of candidate predictors of response, remission, recovery, and relapse across mental disorders

M Solmi, S Cortese, G Vita, M De Prisco, J Radua… - Molecular …, 2023 - nature.com
We aimed to identify diagnosis-specific/transdiagnostic/transoutcome multivariable
candidate predictors (MCPs) of key outcomes in mental disorders. We conducted an …

A Systematic Review of the Clinimetric Properties of the 6-Item Version of the Hamilton Depression Rating Scale (HAM-D6)

N Timmerby, JH Andersen, S Søndergaard… - Psychotherapy and …, 2017 - karger.com
Background: In a study aimed at identifying the items carrying information regarding the
global severity of depression, the 6-item Hamilton Depression Rating Scale (HAM-D6) was …

The clinical characterization of the patient with primary psychosis aimed at personalization of management

M Maj, J van Os, M De Hert, W Gaebel… - World …, 2021 - Wiley Online Library
The current management of patients with primary psychosis worldwide is often remarkably
stereotyped. In almost all cases an antipsychotic medication is prescribed, with second …

A guideline and checklist for initiating and managing clozapine treatment in patients with treatment-resistant schizophrenia

CU Correll, O Agid, B Crespo-Facorro… - CNS drugs, 2022 - Springer
Abstract Treatment-resistant schizophrenia (TRS) will affect about one in three patients with
schizophrenia. Clozapine is the only treatment approved for TRS, and patients should be …

Randomized, double-blind, sham-controlled trial to evaluate the efficacy and tolerability of electroconvulsive therapy in patients with clozapine-resistant schizophrenia

DL Melzer-Ribeiro, IC Napolitano, SA Leite… - Schizophrenia …, 2024 - Elsevier
There is no established treatment for patients with clozapine-resistant schizophrenia (CRS).
Clozapine augmentation strategies with antipsychotics or others substances are effective in …

The clinimetric approach to psychological assessment: a tribute to per bech, MD (1942–2018)

GA Fava, D Carrozzino, L Lindberg… - Psychotherapy and …, 2018 - karger.com
Per Bech, one of the most influential scientists in psychological rating scales, suddenly
passed away in the spring of 2018. He was appointed Professor of Clinical Psychiatry at the …

Clozapine augmentation with cariprazine for negative symptoms: a case series and literature review

E Oloyede, I Clark, S Mace… - Therapeutic …, 2022 - journals.sagepub.com
Only about 50% of patients with treatment-resistant schizophrenia respond to clozapine, and
many more patients continue to experience ongoing and prominent negative symptoms …

Early improvement in PANSS‐30, PANSS‐8, and PANSS‐6 scores predicts ultimate response and remission during acute treatment of schizophrenia

CH Lin, HS Lin, SC Lin, CC Kuo… - Acta Psychiatrica …, 2018 - Wiley Online Library
Objective PANSS‐8 and PANSS‐6 are derived from the 30‐item Positive and Negative
Syndrome Scale (PANSS‐30). We investigate whether PANSS‐8 or PANSS‐6 is a reliable …

Effect of the GLP-1 receptor agonist semaglutide on metabolic disturbances in clozapine-treated or olanzapine-treated patients with a schizophrenia spectrum …

MR Sass, AA Danielsen, O Köhler-Forsberg… - BMJ open, 2023 - bmjopen.bmj.com
Introduction Clozapine and olanzapine are some of the most effective antipsychotics, but
both are associated with weight gain and relevant metabolic disturbances, including pre …

[HTML][HTML] Remote group therapies for cognitive health in schizophrenia-spectrum disorders: Feasible, acceptable, engaging

D Mendelson, É Thibaudeau, G Sauvé… - Schizophrenia Research …, 2022 - Elsevier
Severe cognitive impairments and cognitive distortions are core to schizophrenia-spectrum
disorders (SSDs) and are associated with deteriorated social functioning. Despite well …